drugset / Trial / NCT01365494

Immunogenicity and Safety of Rabies Vaccine, Administered With Two Different Simulated Post Exposure Schedules

NCT01365494

Phase 4 Completed 250 enrolled Novartis Vaccines
RandomizedParallel-groupOpen-labelPrevention

Summary

This study was planned to establish the non-inferiority of Rabipur administered as simulated post exposure Zagreb schedule as compared to Essen schedule, in healthy Indian adult subjects.

Timeline

Start
2011-07
Primary completion
2011-11
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Rabies vaccine Vaccine Intramuscular

Indications